Lei Fu
Impact in
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 5%
Papers in
-
- Cancer therapeutics and mechanisms 22
- Circular RNAs in diseases 8
-
- Tuberculosis Research and Epidemiology 38
- Co-authors
- Yu Lu (35 shared papers)Faxing Ding (2 shared papers)Haihong Huang (13 shared papers)Haitao Xie (1 shared paper)Dali Yin (5 shared papers)Bin Wang (10 shared papers)Shifang Peng (13 shared papers)Bin Wang (8 shared papers)
- Journals
- European Journal of Medicinal Chemistry (9 papers)Antimicrobial Agents and Chemotherapy (7 papers)Journal of Medicinal Chemistry (4 papers)Microbiology Spectrum (3 papers)Cancer Management and Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lei Fu
91 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 126
- Infectious Diseases 729
- Molecular Medicine 101
- Epidemiology 557
- Molecular Biology 914
- Hepatology 90
Countries citing papers authored by Lei Fu
This map shows the geographic impact of Lei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Fu more than expected).
Fields of papers citing papers by Lei Fu
This network shows the impact of papers produced by Lei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Fu. The network helps show where Lei Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 209 | |
| 2 | 2011 | 152 | |
| 3 | 2009 | 129 | |
| 4 | 2017 | 122 | |
| 5 | 2013 | 88 | |
| 6 | 2015 | 78 | |
| 7 | 2016 | 71 | |
| 8 | 2012 | 61 | |
| 9 | 2017 | 58 | |
| 10 | 2019 | 49 | |
| 11 | 2021 | 44 | |
| 12 | 2022 | 42 | |
| 13 | 2016 | 41 | |
| 14 | 2020 | 39 | |
| 15 | 2014 | 34 | |
| 16 | 2020 | 33 | |
| 17 | 2020 | 32 | |
| 18 | 2010 | 27 | |
| 19 | 2018 | 27 | |
| 20 | 2017 | 26 |
About Lei Fu
Lei Fu is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Hepatology and Cancer Research, having authored 96 papers that have together received 2.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (38 papers), Cancer therapeutics and mechanisms (22 papers), Mycobacterium research and diagnosis (20 papers), Hepatitis B Virus Studies (10 papers), MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Infectious Diseases (729 citations), Molecular Medicine (101 citations), Epidemiology (557 citations), Molecular Biology (914 citations) and Hepatology (90 citations). Lei Fu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yu Lu, Faxing Ding, Haihong Huang, Haitao Xie, Dali Yin, Bin Wang, Shifang Peng, Bin Wang, Jian Xu and Fadlo R. Khuri. Their work appears in journals such as European Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Microbiology Spectrum and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.